All In Biotech

Drug Trial Radar · NCT01426386

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme

Last checked: Nov 19, 2026Latest source record: Nov 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 265 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

265

Actual

Start

Sep 2011

Primary completion

Apr 2012

Study completion Mar 2013

Sponsor

Lead sponsor
Ferring PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 31, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 37 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial investigates the effects of several doses of FE 999049 in women undergoing IVF/ICSI (in-vitro fertilisation/intracytoplasmic sperm injection) treatment.

Conditions

  • Infertility

Interventions

  • FE 999049Drug

  • Gonal - FDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Oocytes RetrievedTime frame: Day of oocyte retrieval (up to Day 18 after start of stimulation)

Locations

8 sites in 4 countries. Site status is shown where the registry gives one.

  • UZ Brussel

    Brussels, Belgium

  • UZ Gent

    Ghent, Belgium

  • ICF CUBE

    Prague, Czechia

  • Rigshospitalet

    Copenhagen, Denmark

  • IU Dexeus

    Barcelona, Spain

  • IVI Madrid

    Madrid, Spain

  • IVI Sevilla

    Seville, Spain

  • IVI Valencia

    Valencia, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.